Lead in blood control guideline

Control Guideline for Public Health Units

This protocol applies to all cases in NSW, but excludes children aged less than 5 years who are tested in Broken Hill, as there are locally developed clinical guidelines and response protocols in place for those children.

Response time for starting investigation ​Level of risk
'Urgent' - Within one working day of notification of confirmed case)

 

Extreme risk
  • Children (under 18 years) with blood lead levels greater than or equal to 45 µg/dL
  • Adults with blood lead levels greater than or equal to 70 µg/dL
High risk
  • Children (under 18 years) with blood lead levels greater than or equal to 5 µg/dL and less than 45 µg/dL
  • Female adults of reproductive age (18-49 years) with blood lead levels greater than or equal to 5 µg/dL and less than 70 µg/dL
  • Male adults aged 18 years and older and females not of reproductive age (50+ years) with blood lead levels greater than or equal to 20 µg/dL and less than 70 µg/dL
'Routine' - Within three working days of a notification of a confirmed case

 

Low risk
  • Male adults aged 18 years and older and females not of reproductive age (50+) with blood lead levels greater than or equal to 5 µg/dL and less than 20 µg/dL

Occupational exposure

Where initial case investigation identifies occupational exposure and wider clusters within workplaces or non-compliance with the work health and safety regulation, Public Health Units (PHUs) should provide case details to SafeWork NSW and/or the Resources Regulator (Section 10​).

Case management

The treating doctor is responsible for managing patients with elevated blood lead levels.

Management of people in the same exposure setting as confirmed cases

Recommend blood testing of other people with the same exposure setting as a confirmed case (e.g. household members), or who have been exposed to lead items associated with a confirmed case (e.g. lead-contaminated clothes brought home from work).

 

Environmental management for non-occupational cases

Identify lead sources of confirmed cases, through home assessment or environmental investigation, and recommend interventions to address or minimise exposures.


Last updated: 03 March 2026
Download

​On this page

1. Surveillance objectives

  • Monitoring the epidemiology of blood lead levels and potential exposures in NSW to inform the development of effective prevention strategies in partnership with other agencies
  • Identifying people potentially at risk from a same source as a case to reduce their risk of exposure
  • Referring occupationally acquired cases to SafeWork NSW and/or the Resources Regulator (Section 10) for intervention where there are concerns about workplace clusters or non-compliance with work health and safety legislation​

2. Case definition

Probable case

A capillary blood lead level of ≥5 µg/dL in the absence of a confirmatory venous blood test.

Confirmed case

A venous blood lead level of ≥5 µg/dL.

3. The disease

Sources and routes of exposure

Individuals can absorb lead by breathing air that contains very fine particles of lead or by swallowing contaminated dust, soil, water or food. Young children, especially under 2 years of age, may be exposed to lead from contaminated soil, paint and dust through crawling, hand-to-mouth behaviours and mouthing objects such as toys that are contaminated with lead. Individuals with pica, an eating disorder where people eat things that are not food such as soil and flaking paint may also have increased risk of ingestion of lead. While skin contact with lead can lead to some absorption, it is not the primary pathway of exposure for the general population. Dermal exposure is most likely for people who work with lead or materials containing lead.

Trace amounts of lead can be found across a range of natural sources so most Australians will have 'background' level of blood lead of less than 5 micrograms per decilitre (µg/dL). It is uncommon for someone to have a blood lead level greater than 10 µg/dL. More information on sources of lead is available in the NHMRC 2016 guidelines Managing Individual Exposure to Lead in Australia.

Most people in Australia live in places where there are very small amounts of lead in food, air and soil. There are some towns in Australia, such as Broken Hill, Port Pirie and Mount Isa where there are active lead mines or smelters close to residential and commercial areas. In Broken Hill, there are specific programs in place to screen children for blood lead, educate children and families about lead risks, remediate public lands and reduce emissions.

Environmental lead may be present due to existing or legacy contamination from industry. In some communities, soil may still contain lead deposited from traffic fumes prior to the removal of lead from petrol. Lead based paint used in houses or buildings built before the 1970s is also a source of environmental lead. Peeling paint may be ingested by children, and lead may be inhaled during renovations if fine particles are produced through paint stripping or sanding.

Exposure to lead has substantially reduced in recent decades due to national initiatives which have restricted the addition of lead to paint and petrol, and the reduction of use of lead in consumer goods (e.g., toys, cosmetics and cans). Although the use of lead in petrol and paints in Australia has been restricted, it may still be found in some fuels (aviation gasoline for piston engines and some racing fuels) and paints and finishes on some products (e.g., cars and boats). Lead is still used in lead-acid batteries and some ceramic glazes.

Certain occupations present a risk of lead exposure. Working in mining, smelting, recycled metals, construction and soldering can cause elevated blood levels. If a worker's blood lead level exceeds thresholds defined in NSW Work Health and Safety Regulation 2025, they must be removed from lead-risk work.

In Australia, regulated public drinking water supplies are monitored and may be treated to remove lead to comply with the Australian Drinking Water Guidelines. Some sources of drinking water such as rainwater tanks and groundwater can become contaminated from the leaching of lead from roofs and pipes or from anthropogenic sources.

In recent years, there have been elevated blood lead level cases in members of some communities related to imported Ayurvedic or other traditional remedies, imported cosmetics, spices and food products. While these emerging sources of exposure make up a minority of cases, it is important that they are considered during case investigation. Other sources of lead include hobbies involving recreational shooting (exposure to lead in ammunition), making leaded lights or leaded windows (lead lighting) and making lead sinkers. Cases of severe lead poisoning associated contaminated illicit opium products were also reported in NSW and Victoria in 2018.

Health effects

Public health efforts aim to minimise people's exposure and blood levels as much as possible. The health effects of lead can differ between individuals based on their blood lead level, age, duration of exposure (over the short term or a longer period), and the presence of other health conditions. Lead can be harmful to people of all ages, but the risk of health effects is highest for unborn babies, infants and children under the age of 5 years. Children are born with essentially the same blood lead level as their mother. In a lead contaminated environment, their blood lead level can increase as they begin crawling on floors and when hand to mouth behaviour and mouthing of objects begin. Hand to mouth and mouthing behaviours typically increase between 6 to 9 months and peak at around 2 years of age. In a child with normal development and in a static environment, their blood lead is unlikely to rise after 2 years of age.

Blood lead levels greater than or equal to 10 µg/dL may have harmful effects on many organs and bodily functions. Effects such as increased blood pressure, abnormally low haemoglobin, abnormal kidney function, long-term kidney damage, behavioural problems, cognitive impairment and abnormal brain function have been observed at blood lead levels between 10 µg/dL and 60 µg/dL in adults and children. Encephalopathy generally occurs at blood lead levels of 100-120 µg/dL in adults and at 70-100 µg/dL in children. This condition is characterised by irritability, agitation, poor attention span, headache, confusion, uncoordinated walking or movement, drowsiness, convulsions, seizures or coma. In extreme situations, irreversible brain damage or even death can occur at these elevated blood lead levels.

In 2015, the NHMRC's review of the health effects of lead found an association between reductions in intelligence quotient (IQ) and academic achievement in children at blood lead levels less than 10 µg/dL. There is weaker evidence that blood lead levels less than 5 µg/dL are associated with reductions in IQ or academic achievement. However, the NHMRC review notes that the relative contribution of lead to the above health effects is difficult to determine. The effects of blood lead level less than 10 µg/dL on IQ, academic achievement and behavioural problems are likely to be small, with stronger influences being exerted by other factors such as socioeconomic status, education, parenting style, diet or exposure to other substances.

4. Routine prevention activities

Primary prevention

Primary prevention involves the removal of source lead or remediation if the source can be identified. It includes activities such as ensuring old lead paint that is damaged, disturbed, flaking or deteriorating is safely removed.

Long term primary prevention strategies often require a cross-agency approach, including identifying and sealing off contaminated land and sites, and banning products containing lead. Educating the public on how to minimise contact with lead, such as by providing information on the risks of using products containing lead such as lead flashings used in roofing and alternatives to these products as well as safe practices for hobbies involving lead use (e.g. recreational shooting, fishing, lead lighting and antique restoration) is important.

NSW Health works with communities, other Government agencies and industry on strategies to prevent and manage lead and communicates risk minimisation information to the public.

Secondary prevention

Secondary prevention involves population-based health screening to identify those with elevated blood lead levels so that interventions can be undertaken to reduce further exposure and blood lead levels.

Once blood lead levels have been detected, secondary prevention includes personal strategies to reduce exposure, repeat testing and follow up of cases.

Tertiary prevention

Tertiary prevention is achieved through treatment of high blood lead levels (greater than or equal to 45 µg/dL in children under 18 and in pregnant women, and greater than or equal to 70 µg/dL in adults) using chelation therapy if clinically indicated. It also includes repeat testing and follow up of cases.

5. Data management

Within 5 working days following notification, enter probable and confirmed cases into the NSW Notifiable Conditions Information Management System (NCIMS).

Creation of an exposure event in NCIMS and linking of cases with same exposure source should be done within 10 working days following notification, noting there may be circumstances where it may take longer to ascertain if an exposure is occupational or not. Information about whether the case has occupational exposures may be ascertained through the laboratory notification sent into NCIMS (e.g., if the ordering doctor is an occupational physician, if the blood test has been conducted in an occupational setting or if there are contact details on the form such as a phone number and/or address associated with a workplace) or through the case interview. PHUs should refer occupationally acquired cases to SafeWork NSW and/or the Resources Regulator for intervention where there are concerns about workplace clusters or non-compliance with work health and safety legislation (Section 10​).

6. Laboratory testing

Venous blood lead testing is the standard, accepted and most accurate method for testing individuals and communities for recent exposure to lead. Venous blood is preferred because it is less prone to contamination from lead on the skin.

Point of care testing of capillary blood via finger prick can be used for screening purposes. This is the method generally used as part of the Broken Hill childhood blood lead screening program because it is considered less invasive for children, quicker and more convenient, promoting increased participation rates.

Cases who have a positive capillary blood test result should be considered a probable case and should be confirmed using venous blood testing.

7. Case management

This protocol applies to all cases in NSW, but excludes children aged less than 5 years who are tested in Broken Hill, as there are locally developed clinical guidelines and response protocols in place for those children.

PHU response

Table 1 provides a risk assessment matrix based on blood lead level and age/gender of the case to determine the level of risk and guide the PHU response (outlined in Table 2) to elevated blood lead levels in non-occupational settings.

Table 1. Risk assessment matrix based on blood lead level and age/gender

Blood lead level

Child (< 18 years)
Blood Lead LevelRisk Level
5 µg/dL to < 10 µg/dLHigh
10 µg/dL to < 20 µg/dLHigh
20 µg/dL to < 45 µg/dLHigh
45 µg/dL to < 70 µg/dLExtreme
≥ 70 µg/dLExtreme
Adults
Adult Female (Age 18–49 years)
Blood Lead LevelRisk Level
5 µg/dL to < 10 µg/dLHigh
10 µg/dL to < 20 µg/dLHigh
20 µg/dL to < 45 µg/dLHigh
45 µg/dL to < 70 µg/dLHigh
≥ 70 µg/dLExtreme
Adult Female (Age ≥ 50 years)
Blood Lead LevelRisk Level
5 µg/dL to < 10 µg/dLLow
10 µg/dL to < 20 µg/dLLow
20 µg/dL to < 45 µg/dLHigh
45 µg/dL to < 70 µg/dLHigh
≥ 70 µg/dLExtreme
Adult Male (Age ≥ 18 years)
Blood Lead LevelRisk Level
5 µg/dL to < 10 µg/dLLow
10 µg/dL to < 20 µg/dLLow
20 µg/dL to < 45 µg/dLHigh
45 µg/dL to < 70 µg/dLHigh
≥ 70 µg/dLExtreme

PHU response for non-occupational exposures based on risk category

​​This outlines the PHU response to elevated blood lead in cases with non-occupational exposures.   

Section 10 ​outlines the approach and referral pathways for managing occupational exposures where PHUs identify workplace clusters or non-compliance with work health and safety legislation.

Low risk

Response

  1. Email or fax the treating doctor/general practitioner (GP) the following documents:
    • Letter for low-risk cases (Appendix 3) recommending risk reduction strategies where exposure sources are identified and consideration for testing high-risk household members.
    • A copy of the NSW Health Lead factsheet.

Timeframe

  • Respond within 3 working days of notification.
  • Update case information on NCIMS within 5 working days following notification.

High risk

Response

  1. Call the treating doctor and obtain permission to contact the patient.
  2. Inform the treating doctor of NHMRC recommendations which include:
    • Considering testing other members of the household, particularly children under 5 years of age and people of childbearing age who might share the same exposure.
    • Providing risk reduction strategies to the patient.
    • Considering referral to a paediatrician for children with levels greater than or equal to 20 µg/dL.
    • Considering referral for specialist toxicologist advice for pregnant women.
  3. Interview the case and if exposure is non-occupational, complete the case investigation form (Appendix 1).
  4. Consider environmental investigation if sources of exposure and/or risks cannot be identified through the case interview.
  5. Email or fax the treating doctor/GP the following documents:
  6. Consider sending the case and/or GP information on lead risks, especially if cases are of reproductive age (15–49 years) and are considering pregnancy or are pregnant.

Timeframe

  • Respond within 1 working day of notification.
  • Update case information on NCIMS within 5 working days following notification.

Extreme risk

Response

  • Complete Steps 1–6 for the High Risk category.
  • A PHU medical officer contacts the treating doctor to discuss whether chelation therapy or further specialist referral is required.

Timeframe

  • Respond within 1 day of notification.
  • Update case information on NCIMS within 5 working days after notification.

Public health units should contact the cases resulting from occupational exposures and provide them with their test results and NSW Health factsheet on lead to raise awareness of lead poisoning and how to reduce their exposure to lead.

Clinical management

The managing doctor is responsible for the clinical management or referrals of patients.

PHUs should provide advice to the managing doctor by letter (see Appendices 3 and 4) and or by phone as per above.

Identifying and removing or avoiding the source of lead exposure is crucial in all cases.

The following resources are available to support people who are considering pregnancy or are pregnant:


8. Environmental investigation

​The purpose of an environmental investigation is to identify exposure sources of lead, identify persons exposed to those sources and guide specific interventions.

Environmental investigations are particularly important in settings where vulnerable people may be exposed, for example childcare facilities and social housing. Targeted environmental sampling is more efficient than scattered approaches. However, environmental sampling is expensive and may be misleading. Therefore, identifying and characterising those potential sources that can be ruled out should be the first step.

For all high or extreme risk cases where sources of environmental exposure or risk factors cannot be determined through a case interview (Appendix 1), the PHU should undertake an initial site environmental investigation to identify lead source(s), with lead sampling conducted where appropriate (Appendix 2​).

Further sampling and testing of potential lead sources are then the responsibility of the owner or occupier of the premises or property. The owner or the occupier may be advised to engage a qualified independent assessor or an occupational hygienist to identify or confirm the source. Tenants should be encouraged to report any potential lead hazards to landlords. The PHU may advocate with premises or property owner/s for lead hazards to be assessed and/or addressed.

Where imported cosmetics, remedies, spices, or other products are found to be sources of lead, the PHU should work with Health Protection NSW to engage with the relevant agencies (e.g., NSW Food Authority, Department of Customer Service, Therapeutic Goods Administration, Australian Competition and Consumer Commission) to take appropriate regulatory action to ensure unsafe imported products are not available for sale in Australia. Risks with these products may need to be communicated to affected communities and health professionals working with these communities.

Steps in an environmental investigation include:

  1. Using the environmental investigation checklist (Appendix 2​) to investigate possible environmental sources. This may involve inspecting the case's home or other premises or facilities that the case has had exposure to or contact with.
  2. Onsite lead sampling to help identify and/or confirm lead-containing or lead-contaminated environments, items, food and water sources. The PHU can contact Forensic and Analytical Science Service (FASS) (NSWPATH-FASS-CET-TI@health.nsw.gov.au) to test non‑food samples, or the National Measurement Institute (NMI) (ASB@measurement.gov.au) to test food samples.
  3. Communicating findings from environmental investigation to the case, and to the GP with consent, and providing the case with verbal and written recommendations for lead reduction, abatement and remediation. With consent, PHU may advocate with property owner/s for lead reduction, abatement and/or remediation actions.
  4. Uploading to NCIMS copies of relevant investigation documentation, including reports and communications.

Note: The PHU should advise the case that the information provided does not replace specialised professional expert investigation or advice by an occupational hygienist and it is the responsibility of the owner to undertake their own investigations.

The following links from the US Department of Housing and Urban Development provide some guidance for onsite investigations:

9. Management of people in the same exposure setting

Elevated blood lead levels in adults may be sentinel events that indicate potential exposure for children in the household of the affected adult. This may be due to a hobby the adult is engaged in or through bringing lead contaminated work clothes into the home environment.

Secondary exposure to a lead source can occur if a case wears or brings occupational attire contaminated with lead into the home environment. Therefore, people who live in the same household as the case are considered at risk.

Blood lead testing of family or household members should be recommended by the PHU to the treating practitioner if any of the following risk factors are noted:

  • The family or household member has unexplained health problems or behavioural issues that could be due to lead.
  • The case's family members have been involved in activities that may result in them swallowing, inhaling or touching lead, or a substance that is contaminated with lead.
  • The family includes children under 5 years of age.
  • The family includes people, especially young children, with pica and other behavioural issues that may increase their risk of inhaling or consuming items containing lead. Pica is an eating disorder where a person may eat things that are not usually considered food (e.g., soil, flaking paint).
  • Children under 5 years of age in a household with elevated blood lead levels who may have possibly consumed or used traditional or imported products (such as Ayurvedic medicine and imported cosmetics).

10. Managing cases with occupational exposure

Workplace responsibilities

According to the NSW Work Health and Safety Regulation 2025, workplaces are required to notify occupational exposures resulting in high blood lead levels directly to Work Health and Safety regulators, and these notifications are to be managed by workplaces. Clause 407 of the NSW Work Health and Safety Regulation 2025 also specifies the recommended intervals at which workers who carry out lead risk work should be re-tested based on previous lead test results, gender and reproductive age.

Since 1 July 2021, this legislation has required businesses that conduct 'lead risk work' to remove workers from 'lead risk work' and notify the regulators if:

  • the blood lead level of females of reproductive capacity is greater than or equal to 10 µg/dL, or
  • the blood lead level of males or females not of reproductive capacity is greater than or equal to 30 µg/dL

The worker can return to 'lead risk work' when they have had follow up health monitoring and their blood lead levels drop below:

  • 5 µg/dL for a female of reproductive capacity, or
  • 20 µg/dL for anyone else

Under the NSW Work Health and Safety Regulation 2025 all employers are required to notify SafeWork NSW when it has been determined that work at a site is lead risk work, or when the information provided in a lead risk work notification change. Mine operators also must notify the Resources Regulator when a worker is removed from lead risk work.

​Case referral to SafeWork NSW or the Resource Regulator

If the PHU identifies a cluster of cases with occupational exposures through the NCIMS laboratory notification (e.g., if the test has been ordered by an occupational physician, if the blood test has been conducted in an occupational setting or if there are contact details on the form linked to a workplace) or through case interviews, the PHU may contact SafeWork NSW (and the Resources Regulator for lead risk work related to mines) to ensure that the risk is managed and the workers receive clinical management. Another instance where PHUs may contact the regulators includes when PHUs identify workplace non-compliance with the Work Health and Safety legislation.

Under the Public Health Act 2010 and Health Records and​ Information Privacy Act 2002, notifiable conditions data can only be shared for public health purposes and for purposes directly related to the reason the information was collected. In most circumstances it should not be necessary to share individuals' data with regulators, and if requested by the regulator, individual data should only be shared with the permission of the individual. PHUs must ensure that secure file transfer is used for referrals to regulators when sharing identifying information about individuals with regulators.

PHUs should contact Environmental Health Branch at hssg-ehbsurveillance@health.nsw.gov.au for contact details at SafeWork NSW and the Resources Regulator.

​References

1. Angelon-Gaetz, K.A.; Klaus, Christen; Chaudhry, Ezan A; Bean, Deidre K. Lead in Spices, Herbal Remedies, and Ceremonial Powders Sampled from Home Investigations for Children with Elevated Blood Lead Levels — North Carolina, 2011–2018. MMWR, 2018. 67(46): p. 1290–1294.

2. Hore, Paromita; Alex-Oni, Kolapo; Sedlar, Slavenka; Nagin, Deborah. A spoonful of Lead a 10 year look at spices. Journal of Public Health Management and Practice. January/February 2019. 25 Suppl 1. p S63-S70.

3. Managing Individual Exposure to Lead in Australia - A Guide for Health Practitioners. National Health and Medical Research Council. April 2016. https://www.nhmrc.gov.au/about-us/publications/managing-individual-exposure-lead-australia.

4. Recommended Actions Based on Blood Lead Level. Centers for Disease Control and Prevention. Recommended Actions Based on Blood Lead Level | Childhood Lead Poisoning Prevention | CDC.

5. Schwarcz, Leilani; Crystal, L Begay; Chilton, Lance A; Shirley, J Brian; Seifert, Steven. Childhood Lead Exposure Associated with the Use of Kajal, an Eye Cosmetic from Afghanistan — Albuquerque, New Mexico, 2013. CDC Morbidity and Mortality Weekly Report, 2013. 62(46): p. 917-919.

6. The Environmental Case Management of Lead-exposed Persons: Guidelines for Public Health Units. New Zealand Ministry of Health. March 2021.

​Appendices

Further information

Current as at: Tuesday 3 March 2026
Contact page owner: Environmental Health